Xilio Therapeutics, Inc.

NASDAQ:XLO

1.15 (USD) • At close December 24, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Omzet 2.2632.35702.902000000000000000
Kosten van de omzet 00.4450.4430.4490.460.4920.4990.4890.4730.4450.440.3940.3820.3730.350000
Brutowinst 2.2631.912-0.4432.453-0.46-0.492-0.499-0.489-0.473-0.445-0.44-0.394-0.382-0.373-0.350000
Brutowinstmarge 10.81100.845000000000000000
Onderzoek- en ontwikkelingskosten 10.75911.21610.411.73611.05113.21816.13114.99713.03816.24614.9211.35210.4717.74511.62117.66711.469.1475.636
Algemene en administratieve kosten 6.3075.8156.1396.3946.316.8987.3958.177.1688.3066.3048.2045.4915.2624.8992.9283.1632.32.262
Verkoop- en marketingkosten 0-0.445-0.4435.939000000000000000
Verkoop-, algemene en administratieve kosten 6.3075.375.6965.9456.316.8987.3958.177.1688.3066.3048.2045.4915.2624.8992.9283.1632.32.262
Overige kosten -0.0410.7790.284-2.2540.6130.7610.880.7010.416-0.061-0.129-0.145-0.29-0.174-0.147-0.177-0.19600
Bedrijfskosten 17.02516.58616.09617.68117.36120.11623.52623.16720.20624.55221.22419.55615.96123.00716.5220.59514.62311.518.118
Bedrijfsresultaat -14.762-14.674-16.539-18.13-17.361-20.116-23.526-23.167-20.206-24.552-21.224-19.556-15.961-23.007-16.52-20.595-14.623-11.447-7.898
Bedrijfsresultaat ratio -6.523-6.2260-6.247000000000000000
Totaal overige inkomsten en kosten netto 0.7420.779-0.6640.4750.6130.7610.880.7010.416-0.061-0.129-0.145-0.29-0.174-0.147-0.177-0.196-0.063-0.22
Inkomen voor belasting -14.02-13.925-17.203-17.655-16.748-19.355-22.646-22.466-19.79-24.613-21.353-19.701-16.251-23.181-16.667-20.772-14.819-11.51-8.118
Inkomen voor belasting ratio -6.195-5.9080-6.084000000000000000
Belastingkosten 0001.3790.50.37-1.379-0.701-0.41600.129-0.3940000000
Nettowinst -14.02-13.925-17.203-17.655-16.748-19.355-21.267-21.765-19.374-24.613-21.482-19.701-16.251-23.181-16.667-20.772-14.819-11.51-8.118
Nettowinstmarge -6.195-5.9080-6.084000000000000000
WPA (Winst Per Aandeel) -0.22-0.24-0.62-0.64-0.61-0.7-0.78-0.79-0.71-0.9-0.78-0.98-0.61-0.87-0.63-0.78-0.56-28-19.85
Verwaterde WPA -0.22-0.24-0.62-0.64-0.61-0.7-0.78-0.79-0.71-0.9-0.78-0.98-0.61-0.87-0.63-0.78-0.56-27.98-19.83
EBITDA -14.422-14.229-16.096-17.106-16.901-19.624-23.027-22.678-19.733-24.107-20.784-19.162-15.579-22.634-16.17-20.254-14.307-11.233-7.987
EBITDA ratio -6.373-6.0370-6.093000000000000000